Key result
Elevated brachial-ankle pulse wave velocity mediated 20.5% of the positive relationship between increased age and the prevalence of sarcopenia in patients with type 2 diabetes mellitus.
Why the study?
Arterial stiffness and sarcopenia are common age-related conditions in type 2 diabetes mellitus, but few studies have evaluated the relationship among age, arterial stiffness, and sarcopenia in this population.
Does arterial stiffness mediate the association between increased age and the risk of sarcopenia in patients with type 2 diabetes mellitus?
Cross-Sectional (n=447)
No
Does arterial stiffness mediate the association between increased age and the risk of sarcopenia in patients with type 2 diabetes mellitus?
Effect estimate: Increase of 0.0115 per 1 year increase in age (mediation effect) (95% CI 0.0028-0.0239)
Elevated arterial stiffness, as measured by brachial-ankle pulse wave velocity, partially mediates the association between aging and the development of sarcopenia in patients with type 2 diabetes mellitus.
Observed mediation in T2DM inpatients should not guide therapy; leaves open prospective tests of stiffness-targeted sarcopenia prevention.
Background and Aims: Arterial stiffness and sarcopenia are commonly seen in patients with type 2 diabetes mellitus (T2DM), and both are age-related diseases. However, few studies have addressed the causal relationship between age, arterial stiffness, and sarcopenia, especially in patients with T2DM. This study is aimed at investigating the relationship among age, arterial stiffness, and sarcopenia in patients with T2DM. Methods and Results: This cross-sectional study enrolled 557 inpatients with diabetes at the First Affiliated Hospital of Wenzhou Medical University, China, between June 2020 and July 2021. Patients who were diagnosed with T2DM and underwent examination of dual-energy X-ray absorptiometry, handgrip strength, 6-meter walk speed, and brachial-ankle pulse wave velocity (baPWV, a recognized indicator of arterial stiffness) were enrolled. A total of 447 patients were included. A dose-dependent relationship was found between age and sarcopenia. We also found a dose-dependent relationship between age and baPWV. Similarly, significant dose-dependent relationships were found across baPWV tertiles with higher prevalence of sarcopenia. Then, a mediation analysis was performed to explore the mediation effect of arterial stiffness on age-associated sarcopenia. We found that the prevalence of sarcopenia increased by 0.0115 (95% CI, 0.0028-0.0239) per 1 year increase in age by the mediation effect of baPWV and that the direct effect of aging on sarcopenia was 0.0441 (95% CI, 0.0101-0.0909) per 1 year older. baPWV mediated 20.5% of the positive relationship between increased age and the prevalence of sarcopenia. Conclusions: Elevated baPWV partially mediates the association of age and sarcopenia among patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2023) conducted a cross-sectional in Type 2 diabetes mellitus (n=447). Increased age and elevated brachial-ankle pulse wave velocity (baPWV) was evaluated on Prevalence of sarcopenia (Increase of 0.0115 per 1 year increase in age (mediation effect), 95% CI 0.0028-0.0239). Elevated brachial-ankle pulse wave velocity mediated 20.5% of the positive relationship between increased age and the prevalence of sarcopenia in patients with type 2 diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: